Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Working Capital Changes: 2018-2024

Historic Other Working Capital Changes for Black Diamond Therapeutics (BDTX) over the last 7 years, with Dec 2024 value amounting to -$3.4 million.

  • Black Diamond Therapeutics' Other Working Capital Changes fell 443.77% to -$3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.7 million, marking a year-over-year decrease of 150.16%. This contributed to the annual value of -$3.4 million for FY2024, which is 9.28% down from last year.
  • As of FY2024, Black Diamond Therapeutics' Other Working Capital Changes stood at -$3.4 million, which was down 9.28% from -$3.1 million recorded in FY2023.
  • Black Diamond Therapeutics' 5-year Other Working Capital Changes high stood at $3.4 million for FY2020, and its period low was -$3.4 million during FY2024.
  • In the last 3 years, Black Diamond Therapeutics' Other Working Capital Changes had a median value of -$3.1 million in 2023 and averaged -$3.1 million.
  • As far as peak fluctuations go, Black Diamond Therapeutics' Other Working Capital Changes soared by 235.84% in 2020, and later slumped by 150.16% in 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Other Working Capital Changes (Yearly) stood at $3.4 million in 2020, then tumbled by 150.16% to -$1.7 million in 2021, then plummeted by 64.70% to -$2.8 million in 2022, then decreased by 9.61% to -$3.1 million in 2023, then dropped by 9.28% to -$3.4 million in 2024.